Related references
Note: Only part of the references are listed.Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer
Alessandra Ciucci et al.
GYNECOLOGIC ONCOLOGY (2014)
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort
Rudolf Kaaks et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice
Hachidai Hirakawa et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
R. J. Kurman
ANNALS OF ONCOLOGY (2013)
Clear cell cancer of the ovary
Richard T. Penson et al.
CURRENT OPINION IN ONCOLOGY (2013)
Ovarian Brenner tumour: A morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium
Elisabetta Kuhn et al.
EUROPEAN JOURNAL OF CANCER (2013)
Reproductive characteristics in relation to ovarian cancer risk by histologic pathways
M. A. Merritt et al.
HUMAN REPRODUCTION (2013)
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh et al.
LANCET ONCOLOGY (2013)
DHEA metabolites activate estrogen receptors alpha and beta
Kristy K. Michael Miller et al.
STEROIDS (2013)
Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression
Miriam S. Butler et al.
HORMONES & CANCER (2013)
Hormone response in ovarian cancer: time to reconsider as a clinical target?
Francesmary Modugno et al.
ENDOCRINE-RELATED CANCER (2012)
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
Ahmed Elattar et al.
GYNECOLOGIC ONCOLOGY (2012)
Hormone concentrations in the homogenates of ovarian tissue and blood serum in postmenopausal women not using hormone therapy
Jacek Brodowski et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Clinicopathologic and Immunohistochemical Features of Ovarian Clear Cell Carcinomas in Comparison With Type I and Type II Tumors
Gian Franco Zannoni et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Celeste Leigh Pearce et al.
LANCET ONCOLOGY (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Premenopausal serum androgens and breast cancer risk: a nested case-control study
Anne Zeleniuch-Jacquotte et al.
BREAST CANCER RESEARCH (2012)
Ovarian Cancer is an Imported Disease: Fact or Fiction?
Elisabetta Kuhn et al.
CURRENT OBSTETRICS AND GYNECOLOGY REPORTS (2012)
Circulating Sex Steroids during Pregnancy and Maternal Risk of Non-epithelial Ovarian Cancer
Tianhui Chen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
Agnieszka Halon et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
Bjorn Nodin et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Relationship between Epidemiologic Risk Factors and Hormone Receptor Expression in Ovarian Cancer: Results from the Nurses' Health Study
Jonathan L. Hecht et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The Importance of Growth Factors and Steroid Hormones in Ovarian Cancer
Simon P. Langdon et al.
ONKOLOGIE (2009)
Plasma androgen concentrations and risk of incident ovarian cancer
Shelley S. Tworoger et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Endogenous androgens and risk of epithelial ovarian cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)
Sabina Rinaldi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2-to 3-year period
Stacey A. Missmer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Androgen levels in adult females: Changes with age, menopause, and oophorectomy
SL Davison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC)
R Kaaks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Measurement of free testosterone in normal women and women with androgen deficiency: Comparison of methods
KK Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Circulating levels of sex steroid hormones and risk of ovarian cancer
A Lukanova et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
European prospective investigation into cancer and nutrition (EPIC):: study populations and data collection
E Riboli et al.
PUBLIC HEALTH NUTRITION (2002)
Share Paper
